Ford has teamed up with gig-economy start-up Postmates to develop its autonomous vehicle technology. Ford’s VP of autonomous vehicles and electrification told Cheddar he hopes to learn exactly how self-driving cars can be used. “We’re going to learn how the different forms of things that are being delivered work with AVs,” Sherif Marakby said. “Maybe some things work perfectly with autonomous vehicles, maybe some things don’t.” Postmates offers on-demand delivery from small businesses to area residents. The company says it operates in over 250 cities and makes about 2.5 deliveries per month. Ford is one of several car makers looking to use self-driving cars as a service. Volkswagen and Hyundai recently announced a partnership with Aurora, an autonomous technology start-up, to roll out self driving vehicles. For full interview [click Here](https://cheddar.com/videos/fords-smart-vehicle-smart-world).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More